MedTrace Logo

Phytosterol Supplementation and Cardiovascular Risk

NCT00153738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2014-03-13

No results posted yet for this study

Summary

This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.

Conditions

  • Hypercholesteremia

Interventions

DRUG

phytosterol

Sponsors & Collaborators

  • Cargill

    collaborator INDUSTRY

  • The Cooper Institute

    lead OTHER

Principal Investigators

  • Conrad Earnest, PhD · The Cooper Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Completion
2005-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153738 on ClinicalTrials.gov